Zobrazeno 1 - 10
of 561
pro vyhledávání: '"Montezuma D"'
Autor:
Montezuma D; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; IMP Diagnostics, Porto, Portugal; Doctoral Program in Medical Sciences, ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre Raquel Seruca (Porto.CCC), Porto, Portugal. Electronic address: diana.felizardo@impdiagnostics.com., Oliveira SP; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: s.oliveira@nki.nl., Tolkach Y; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Institute of Pathology, University Hospital Cologne, Cologne, Germany., Boor P; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany., Haragan A; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Royal Liverpool University Hospital, Liverpool, United Kingdom., Carvalho R; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Department of Pathology, MVZ Helios Klinikum Emil von Behring, Berlin, Germany., Della Mea V; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Department of Mathematics, Computer Science and Physics, University of Udine, Udine, Italy., Kiehl TR; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Medical Informatics, Berlin, Germany., Leh S; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Department of Pathology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Yousif M; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Department of Pathology, University of Michigan Medical School, Michigan, USA., Ameisen D; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Imginit SAS, Paris, France., Șerbănescu MS; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Department of Medical Informatics and Biostatistics, University of Medicine and Pharmacy of Craiova, Romania., Zerbe N; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Medical Informatics, Berlin, Germany., L'Imperio V; European Society of Digital and Integrative Pathology (ESDIP), Lisboa, Portugal; School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; Department of Pathology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2024 Nov 28, pp. 102203. Date of Electronic Publication: 2024 Nov 28.
Autor:
Nunes JD; INESC TEC - Institute for Systems and Computer Engineering, Technology and Science, R. Dr. Roberto Frias, Porto, 4200-465, Portugal; University of Porto - Faculty of Engineering, R. Dr. Roberto Frias, Porto, 4200-465, Portugal. Electronic address: joao.d.fernandes@inesctec.pt., Montezuma D; IMP Diagnostics, Praça do Bom Sucesso, 4150-146 Porto, Portugal; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/[RISE@CI-IPOP], Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal; Doctoral Programme in Medical Sciences, School of Medicine and Biomedical Sciences - University of Porto (ICBAS-UP), Porto, Portugal., Oliveira D; IMP Diagnostics, Praça do Bom Sucesso, 4150-146 Porto, Portugal., Pereira T; INESC TEC - Institute for Systems and Computer Engineering, Technology and Science, R. Dr. Roberto Frias, Porto, 4200-465, Portugal; FCTUC - Faculty of Science and Technology, University of Coimbra, Coimbra, 3004-516, Portugal., Cardoso JS; INESC TEC - Institute for Systems and Computer Engineering, Technology and Science, R. Dr. Roberto Frias, Porto, 4200-465, Portugal; University of Porto - Faculty of Engineering, R. Dr. Roberto Frias, Porto, 4200-465, Portugal.
Publikováno v:
Medical image analysis [Med Image Anal] 2025 Jan; Vol. 99, pp. 103360. Date of Electronic Publication: 2024 Oct 05.
Autor:
Guzmán-Calderón GE; Gastroenterology Unit of Angloamericana Clinic.; Gastroenterology Unit of Hospital Nacional Edgardo Rebagliati Martins., Chirinos J; Gastroenterology Unit of Angloamericana Clinic., Díaz-Arocutipa C; Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru., Vesco E; Gastroenterology Unit of Angloamericana Clinic., Huerta-Mercado J; Gastroenterology Unit of Angloamericana Clinic., Cedrón H; Gastroenterology Unit of Angloamericana Clinic., Montezuma D; Gastroenterology Unit of Angloamericana Clinic., Poppele G; Gastroenterology Unit of Angloamericana Clinic., Aparicio JR; Gastroenterology Unit oh Hospital General Universitario de Alicante, Alicante, Spain.
Publikováno v:
Journal of clinical gastroenterology [J Clin Gastroenterol] 2024 Jul 15. Date of Electronic Publication: 2024 Jul 15.
Autor:
Pires-Luis, A., Montezuma, D., Vieira, J., Ramalho-Carvalho, J., Santos, C., Teixeira, M., Jerónimo, C., Henrique, R.
Publikováno v:
In Experimental and Molecular Pathology December 2018 105(3):352-356
Autor:
Vieira R; IMP Diagnostics, Edifício Trade Center 61, Praça Do Bom Sucesso, 4150-146, Porto, Portugal., Montezuma D; IMP Diagnostics, Edifício Trade Center 61, Praça Do Bom Sucesso, 4150-146, Porto, Portugal; Doctoral Programme in Medical Sciences, School of Medicine and Biomedical Sciences - University of Porto (ICBAS-UP), Porto, Portugal. Electronic address: diana.felizardo@impdiagnostics.com., Barbosa C; Department of Pathology, Hospital Universitário Agostinho Neto, Cabo Verde., Macedo Pinto I; IMP Diagnostics, Edifício Trade Center 61, Praça Do Bom Sucesso, 4150-146, Porto, Portugal.
Publikováno v:
Tumour virus research [Tumour Virus Res] 2024 Jun; Vol. 17, pp. 200280. Date of Electronic Publication: 2024 May 09.
Autor:
Teixeira-Marques A; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal., Monteiro-Reis S; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.; INEGI-LAETA, Faculty of Engineering, University of Porto, Campus FEUP, Rua Dr. Roberto Frias, 400, 4600-465, Porto, Portugal., Montezuma D; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.; IMP Diagnostics, Praça do Bom Sucesso, 61, Sala 808, 4150-146, Porto, Portugal.; Doctoral Programme in Medical Sciences, ICBAS-School of Medicine and Biomedical Sciences-University of Porto, R. Jorge de Viterbo Ferreira 228, 4050-313, Porto, Portugal., Lourenço C; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, R. Alfredo Allen 208, 4200-135, Porto, Portugal.; Doctoral Programme in Biomedical Sciences, ICBAS-School Medicine and Biomedical Sciences, University of Porto, R. Jorge de Viterbo Ferreira 228, 4050-313, Porto, Portugal., Oliveira MC; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal., Constâncio V; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.; Doctoral Programme in Biomedical Sciences, ICBAS-School Medicine and Biomedical Sciences, University of Porto, R. Jorge de Viterbo Ferreira 228, 4050-313, Porto, Portugal., Sequeira JP; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.; Doctoral Programme in Biomedical Sciences, ICBAS-School Medicine and Biomedical Sciences, University of Porto, R. Jorge de Viterbo Ferreira 228, 4050-313, Porto, Portugal.; Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain., Carvalho-Maia C; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal., Freitas R; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.; Department of Urology, Portuguese Oncology Institute of Porto (IPOPorto), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal., Martens-Uzunova ES; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Be-331, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Vasconcelos MH; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, R. Alfredo Allen 208, 4200-135, Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, R. Alfredo Allen 208, 4200-135, Porto, Portugal.; Department of Biological Sciences, FFUP-Faculty of Pharmacy, University of Porto, R. Jorge de Viterbo Ferreira 228, 4050-313, Porto, Portugal., Henrique R; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.; Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), R. Jorge de Viterbo Ferreira 228, 4050-313, Porto, Portugal., Jerónimo C; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal. carmenjeronimo@ipoporto.min-saude.pt.; Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), R. Jorge de Viterbo Ferreira 228, 4050-313, Porto, Portugal. carmenjeronimo@ipoporto.min-saude.pt.
Publikováno v:
Scientific reports [Sci Rep] 2024 May 28; Vol. 14 (1), pp. 12267. Date of Electronic Publication: 2024 May 28.
Autor:
Neto PC; Institute for Systems and Computer Engineering, Technology and Science (INESC TEC), R. Dr. Roberto Frias, Porto, 4200-465, Porto, Portugal. pedro.d.carneiro@inesctec.pt.; Faculty of Engineering, University of Porto (FEUP), R. Dr. Roberto Frias, Porto, 4200-465, Porto, Portugal. pedro.d.carneiro@inesctec.pt., Montezuma D; IMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal. diana.felizardo@impdiagnostics.com.; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida 865, Porto, 4200-072, Porto, Portugal. diana.felizardo@impdiagnostics.com.; Doctoral Programme in Medical Sciences, School of Medicine and Biomedical Sciences - University of Porto (ICBAS-UP), R. Jorge de Viterbo Ferreira 228, Porto, 4050-313, Porto, Portugal. diana.felizardo@impdiagnostics.com., Oliveira SP; Institute for Systems and Computer Engineering, Technology and Science (INESC TEC), R. Dr. Roberto Frias, Porto, 4200-465, Porto, Portugal. s.oliveira@nki.nl.; Faculty of Engineering, University of Porto (FEUP), R. Dr. Roberto Frias, Porto, 4200-465, Porto, Portugal. s.oliveira@nki.nl., Oliveira D; IMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal., Fraga J; Department of Pathology, IPO-Porto, R. Dr. António Bernardino de Almeida 865, Porto, 4200-072, Porto, Portugal., Monteiro A; IMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal., Monteiro J; IMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal., Ribeiro L; IMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal., Gonçalves S; IMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal., Reinhard S; Institute of Pathology, University of Bern, Uni Bern, Murtenstrasse 31, Bern, 3008, Bern, Switzerland., Zlobec I; Institute of Pathology, University of Bern, Uni Bern, Murtenstrasse 31, Bern, 3008, Bern, Switzerland., Pinto IM; IMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal., Cardoso JS; Institute for Systems and Computer Engineering, Technology and Science (INESC TEC), R. Dr. Roberto Frias, Porto, 4200-465, Porto, Portugal.; Faculty of Engineering, University of Porto (FEUP), R. Dr. Roberto Frias, Porto, 4200-465, Porto, Portugal.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2024 Apr 03; Vol. 8 (1), pp. 83. Date of Electronic Publication: 2024 Apr 03.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Magalhães G; Histopathology Department, Portsmouth Hospital University NHS Trust, Portsmouth, UK.; Department of Pathological Anatomy, School of Health Polytechnic of Porto (ESS|P.PORTO), Porto, Portugal., Calisto R; Department of Pathological Anatomy, School of Health Polytechnic of Porto (ESS|P.PORTO), Porto, Portugal.; Department of Pathological Anatomy, Hospital do Divino Espírito Santo, Ponta Delgada, Portugal., Freire C; Department of Pathological Anatomy, School of Health Polytechnic of Porto (ESS|P.PORTO), Porto, Portugal.; Department of Pathological Anatomy, Hospital do Divino Espírito Santo, Ponta Delgada, Portugal., Silva R; Department of Pathological Anatomy, School of Health Polytechnic of Porto (ESS|P.PORTO), Porto, Portugal.; Centro de Investigação em Saúde e Ambiente, ESS,P.PORTO, Porto, Portugal., Montezuma D; Research & Development Unit, IMP Diagnostics, Porto, Portugal.; School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, Portugal., Canberk S; Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.; Cancer Signalling & Metabolism, Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal., Schmitt F; Department of Pathology, Faculty of Medicine of University of Porto, Porto, Portugal.; CINTESIS@RISE, Health Research Network, Alameda Prof. Hernâni Monteiro, Portugal.
Publikováno v:
Journal of histotechnology [J Histotechnol] 2024 Mar; Vol. 47 (1), pp. 39-52. Date of Electronic Publication: 2023 Oct 23.
Autor:
Pinho, J.1 julianapinho18@gmail.com, Montezuma, D.2, Monteiro, P.2, Dinis‐Ribeiro, M.3, Bastos, P.3
Publikováno v:
Cytopathology. Oct2018, Vol. 29 Issue 5, p478-481. 4p.